Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 79(17): 4439-4452, 2019 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-31273063

RESUMO

Although EGFR mutant-selective tyrosine kinase inhibitors (TKI) are clinically effective, acquired resistance can occur by reactivating ERK. We show using in vitro models of acquired EGFR TKI resistance with a mesenchymal phenotype that CXCR7, an atypical G protein-coupled receptor, activates the MAPK-ERK pathway via ß-arrestin. Depletion of CXCR7 inhibited the MAPK pathway, significantly attenuated EGFR TKI resistance, and resulted in mesenchymal-to-epithelial transition. CXCR7 overexpression was essential in reactivation of ERK1/2 for the generation of EGFR TKI-resistant persister cells. Many patients with non-small cell lung cancer (NSCLC) harboring an EGFR kinase domain mutation, who progressed on EGFR inhibitors, demonstrated increased CXCR7 expression. These data suggest that CXCR7 inhibition could considerably delay and prevent the emergence of acquired EGFR TKI resistance in EGFR-mutant NSCLC. SIGNIFICANCE: Increased expression of the chemokine receptor CXCR7 constitutes a mechanism of resistance to EGFR TKI in patients with non-small cell lung cancer through reactivation of ERK signaling.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Resistencia a Medicamentos Antineoplásicos , Neoplasias Pulmonares/tratamento farmacológico , Inibidores de Proteínas Quinases/farmacologia , Receptores CXCR/metabolismo , Animais , Carcinoma Pulmonar de Células não Pequenas/metabolismo , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Linhagem Celular Tumoral , Resistencia a Medicamentos Antineoplásicos/genética , Transição Epitelial-Mesenquimal/genética , Receptores ErbB/antagonistas & inibidores , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/mortalidade , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/genética , Camundongos Transgênicos , Mutação , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/genética , Receptores CXCR/genética , beta-Arrestinas/metabolismo
2.
Talanta ; 170: 97-102, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-28501220

RESUMO

7,8-hydroxy-2'-deoxyguanosine (8-OHdG) is an abundant DNA lesion formed by oxidation of the nucleoside 2'-deoxyguanosine (2-dG) and one of the most studied and accepted oxidative stress biomarkers. 8-OHdG has a strong carcinogenic potential, and prolonged oxidative stress heightens pathological conditions and especially cancer risk. Our aim was to develop, validate and apply a reliable method to assess DNA oxidation in genomic cellular DNA of sensible target organs such as brain. A procedure to isolate and digest the DNA of brain tissue properly for further detection of 8-OHdG and 2-dG by Ultra Performance Liquid Chromatography-tandem Mass Spectrometry (UPLC-MS/MS) was optimized. The UPLC-MS/MS was validated following the American Food and Drug Administration (FDA) Guidelines using mice pups' brain samples. To demonstrate the applicability of the UPLC-MS/MS method, 8-OHdG/2-dG ratio was determined in brain tissue of 1day old newborn mice pups (P1) in a model of hypoxia pre-conditioning during fetal-to-neonatal transition. We found that hypoxia at birth (FiO2 0.14) and for 8h thereafter induced lower levels of DNA oxidation in mice pups and rendered even protective against a postnatal asphyxia/reoxygenation insult compared with fetal to neonatal transition in room air. We conclude that the UPLC-MS/MS method developed has proven suitable for the analysis of DNA oxidation biomarker 8-OHdG/2-dG ratio in tissue samples from newborn mice pups. We aim to apply this method in future studies aiming to provide a deeper insight into the mechanisms of oxidation DNA caused during neonatal asphyxia and resuscitation.


Assuntos
Encéfalo/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , DNA/metabolismo , Desoxiguanosina/análogos & derivados , Espectrometria de Massas em Tandem/métodos , 8-Hidroxi-2'-Desoxiguanosina , Animais , DNA/química , Desoxiguanosina/química , Desoxiguanosina/metabolismo , Hidrólise , Camundongos , Camundongos Endogâmicos C57BL
3.
Free Radic Biol Med ; 85: 1-11, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25845487

RESUMO

The aim of our study was to investigate in the SKH-1 hairless mouse model the effect of pterostilbene (Pter), a natural dimethoxy analog of resveratrol (Resv), against procarcinogenic ultraviolet B radiation (UVB)-induced skin damage. Pter prevented acute UVB (360 mJ/cm(2))-induced increase in skin fold, thickness, and redness, as well as photoaging-associated skin wrinkling and hyperplasia. Pter, but not Resv, effectively prevented chronic UVB (180 mJ/cm(2), three doses/week for 6 months)-induced skin carcinogenesis (90% of Pter-treated mice did not develop skin carcinomas, whereas a large number of tumors were observed in all controls). This anticarcinogenic effect was associated with (a) maintenance of skin antioxidant defenses (i.e., glutathione (GSH) levels, catalase, superoxide, and GSH peroxidase activities) close to control values (untreated mice) and (b) an inhibition of UVB-induced oxidative damage (using as biomarkers 8-hydroxy-2'-deoxyguanosine, protein carbonyls, and isoprostanes). The molecular mechanism underlying the photoprotective effect elicited by Pter was further evaluated using HaCaT immortalized human keratinocytes and was shown to involve potential modulation of the Nrf2-dependent antioxidant response.


Assuntos
Neoplasias Induzidas por Radiação/prevenção & controle , Protetores contra Radiação/administração & dosagem , Neoplasias Cutâneas/prevenção & controle , Pele/efeitos da radiação , Estilbenos/administração & dosagem , Raios Ultravioleta , Animais , Linhagem Celular Transformada , Feminino , Camundongos , Camundongos Pelados , Estresse Oxidativo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...